CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 814 enrolled
Drug / intervention
Insulin Analog Mid Mixture +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03018938
NCT03018938Phase 4Completed
CompareCT.gov

Comparison Between Basal Insulin Analog and Insulin Analog Mid Mixture AS Starter Insulin for Chinese Patients With Type 2 Diabetes Mellitus (CLASSIC Study)

Eli Lilly and Company·interventional·Posted Jan 12, 2017·Updated Mar 18, 2020

In Brief

A Phase 4 clinical trial evaluating Insulin Analog Mid Mixture and Basal Insulin Analog for Type 2 Diabetes Mellitus. Completed, enrolled 814 participants across 32 sites.

Detailed Summary

The purpose of this study is to compare the effectiveness of basal insulin analog and insulin analog mid mixture in Chinese participants with type 2 diabetes mellitus.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 12, 2017
Enrollment StartFeb 6, 2017
Primary CompletionFeb 19, 2019
Study CompletionJul 12, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.5 years ago

Interventions

Insulin Analog Mid Mixturedrug

Administered SC

Basal Insulin Analogdrug

Administered SC